Abstract
In order to understand some of the ethical dilemmas that face hospice programs in the United States, one must understand the Medicare Hospice Benefit, which is the model by which hospice programs provide palliative care to terminally ill patients in the United States. Unlike palliative care programs outside the United States, patients must have a prognosis of 6 months or less to receive hospice care under the Medicare Hospice Benefit. Care is reimbursed on a per diem basis, and inpatient care is restricted to pain and symptom management that cannot be managed in another setting. Ethical dilemmas that face physicians referring patients to hospice programs include the ability of clinicians to predict accurately a patient prognosis of 6 months or less, and to what extent hospice programs and clinicians are obligated to provide patients with full information about their illness, as the Medicare Hospice Benefit requires that patients sign an informed consent in order to elect the hospice benefit. There are ethical dilemmas that affect day-to-day patient management in palliative care programs including physician concern over the use of morphine because of possible respiratory depression in the advanced cancer patient, the question of providing enteral or parenteral nutritional support to patients who refuse to eat near the end of life, and the question of providing parenteral fluids to patients who are unable to take fluids during the terminal phases of illness. A final ethical dilemma concerns the methodology for quality of life research in palliative care. By following current research dogma, and only considering patient-generated data as valid, the patient population that most needs to be studied is excluded. A new methodology specifically for palliative care research is needed to provide information on the patients who are cognitively or physically impaired and unable to provide input regarding their needs near the end of life.
Similar content being viewed by others
References
Addington-Hall JM, MacDonald LD, Anderson HR (1990) Can the Spitzer quality of life index help to reduce prognostic uncertainty in terminal care? Br J Cancer 62:695–699
American College of Physicians (1989) Parenteral nutrition in patients receiving cancer chemotherapy. Ann Intern Med 110:734
American College of Physicians (1990) Harm is net result of TPN in cancer. Pharmacy Pract News, January
Apilanez RV, Gonzalez de Langarica LR, Arribas EG (1987) Terminal illness syndrome. In: Fourth European Conference on Clinical Oncology and Cancer Nursing, Madrid, Federation of European Cancer Societies, p 193
Baines M (1988) Nausea and vomiting in the patient with advanced cancer. J Pain Symptom Manage 3:81–85
Bayer R, Feldman E (1982) Hospice under the medicare wing. Hastings Cent Rep 12:5–6
Billings JA (1985) Comfort measures for the terminally ill. Is dehydration painful? J Am Geriatr Soc 33:808–810
Brennan MF (1981) Total parenteral nutrition in the management of the cancer patient. Annu Rev Med 32:233–243
Brescia FJ (1993) Specialized care of the terminally ill. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer, principles and practice of oncology, 4th edn. Lippincott, Philadelphia, pp 2501–2508
Brescia FJ, Adler D, Gray G, et al (1990) Hospitalized advanced cancer patients: a profile. J Pain Symptom Manage 5:221–227
Brody H, Lynn J (1984) The physician's responsibility under the new Medicare reimbursement for hospice care. N Engl J Med 310:920–921
Bruera E (1990) Ambulatory infusion devices in the continuing care of patients with advanced diseases. J Pain Symptom Manage 5:287–296
Bruera E, MacDonald RN (1988) Nutrition in cancer patients: an update and review of our experience. J Pain Symptom Manage 3:133–140
Bruera E, Roca E, Cedaro L, et al (1985) Action of oral methylprednisolone in terminal cancer patients. Cancer Treat Rep 69:751–754
Bruera E, Macmillan K, Kuehn N, et al (1990) A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer. Cancer 66:1279–1282
Bruera E, Macmillan K, Pither J, MacDonald RN (1990) Effects of morphine on the dyspnea of terminal cancer patients. J Pain Symptom Manage 5:341–344
Bruera E, MacEachern T, Ripamonti C, Hanson J (1993) Subcutaneous morphine for dyspnea in cancer patients. Ann Intern Med 119:906–907
Burge FI (1993) Dehydration symptoms of palliative care cancer patients. J Pain Symptom Manage 8:454–464
Burge FI, King DB, Willison D (1990) Intravenous fluids and the hospitalized dying: a medical last rite? Can Fam Physician 36:883–886
Burt ME, Gorschboth CM, Brennan MF (1982) A controlled prospective randomized trial evaluating the metabolic effects of enteral and parenteral nutrition in the cancer patient. Cancer 49:1092–1105
Byrne P, Dunstan GR, Jakobovits I (1991) Hospice care: Jewish reservations considered in a comparative ethical study. Palliat Med 5:187–200
Campbell-Taylor I, Fisher RH (1987) The clinical case against tube feeding in palliative care in the elderly. J Am Geriatr Soc 35:1100–1104
Casseleith BR, Lusk EJ, Miller DJ, et al (1985) Psychosocial correlates of survival in advanced malignant diseases. N Engl J Med 312:1551–1555
Centeno-Cortes C (1994) Questioning diagnosis disclosure in terminal cancer patients: a prospective study evaluating patients' responses. Palliat Med 8:39–44
Ciocon JO, Silverstone FA, Graver LM, Foley CJ (1988) Tube feedings in elderly patients. Indications, benefits, and complications. Arch Intern Med 148:429–433
Collaud T, Rapin CH (1991) Dehydration in dying patients: study with physicians in French-speaking Switzerland. J Pain Symptom Manage 6:230–240
Corless IB (1983) The hospice movement in North America. In: Corr CA, Coor DM (eds) Hospice care, principles and practice. Springer, Berlin Heidelberg New York, pp 335–351
Cowcher K, Hanks GW (1990) Longterm management of respiratory symptoms in advanced cancer. J Pain Symptom Manage 5:320–330
Demer C, Johnston-Anderson AV, Tobin R, et al (1992) Cost of hospice care: late versus early entry (abstract). Proc Am Soc Clin Oncol 11:392
Dunn SM, Patterson PU, Butow PN, et al (1993) Cancer by another name: a randomized trial of the effects of euphemism and uncertainly in communicating with cancer patients. J Clin Oncol 11:989–996
Emanuel EJ, Emanuel LL (1994) The economics of dying. The illusion of cost savings at the end of life. N Engl J Med 330:540–544
Ettinger AB, Portenoy RK (1988) The use of corticosteroids in the treatment of symptoms associated with cancer. J Pain Symtom Manage 3:99–103
Evans C, McCarthy, M (1985) Prognostic uncertainty in terminal care: can the Karnofsky Index help? Lancet 1:1204–1206
Evans WK, Nixon DW, Daly JM, et al (1987) A randomized study of oral nutrition support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer. J Clin Oncol 5:113–124
Farr WC (1990) The use of corticos-steroids for symptom management in terminally ill patients. Am J Hospice Care 7:41–46
Forster LE, Lynn J (1988) Predicting life span for applicants to inpatient hospice. Arch Intern Med 148:2540–2543
Forster LE, Lynn J (1989) The use of physiologic measures and demographic variables to predict longevity among inpatient hospice applicants. Am J Hospice Care 6:31–34
Forty-two Code of Federal Regulations (1993) Part 418. Medicare Hospice Regulations
Hanks GE, Myers CE, Scardino PT (1993) Cancer of the prostate. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 4th edn. Lippincott, Philadelphia, pp 1073–1113
Harris JR, Morrow M, Bonadonna G (1993) Cancer of the breast. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 4th edn. Lippincott, Philadelphia, pp 1264–1332
Heber D, Byerley LO, Chi J, et al (1986) Pathophysiology of malnutrition in the adult cancer patient. Cancer 58:1867–1873
Kane RL, Wales J, Bernstein L, et al (1984) A randomised controlled trial of hospice care. Lancet I:890–894
Kaye P (1990) Notes on symptom control in hospice and palliative care. Hospice Education Institute, Essex, Conn, pp 27–29
Kidder D (1988) The impact of hospice on the health care costs of terminal cancer patients. In: Mor V, Greer D, Kastenbaum R (eds) The hospice experiment. Johns Hopkins, Baltimore, pp 48–68
Kidder D (1992) The effects of hospice coverage on Medicare expenditures. Health Serv Res 27:195–217
Kinzbrunner BM (1994) Hospice: what to do when anti-cancer therapy is no longer appropriate, effective, or desired. Semin Oncol (in press)
Klein S (1993) Clinical efficacy of nutritional support in patients with cancer. Oncology 7 [Suppl]:87–92
Klein S, Simes J, Blackburn GL (1986) Total parenteral nutrition and cancer clinical trials. Cancer 58:1378–1386
Koretz RL (1984) Parenteral nutrition: is it oncologically logical? J Clin Oncol 2:534–538
Lack S (1983) The hospice concept — the adult with advanced cancer. In: Corr CA, Coor DM (eds) Hospice care, principles and practice. Springer, Berlin Heidelberg New York, pp 42–54
Levy MH, Catalano RB (1985) Control of common physical symptoms other than pain in patients with terminal disease. Semin Oncol 12:411–430
Light RW, Muro JR, Sato RI, et al (1989) Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 139:126–133
Loprinzi CL (1993) Pharmacologic management of cancer anorexia/cachexia. Oncology 7 [Suppl]:101–103
Loprinzi C Ellison NM, Schaid DJ, et al (1990) Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst 82:1127–1132
Loprinzi CL, Goldberg RG, Su JQ, et al (1993) Randomized double-blind placebo controlled trial evaluating hydrazine sulfate in patients with newly diagnosed non-small cell lung cancer (abstract). Proc Am Soc Clin Oncol 12:337
Loprinzi CL, Michalak JC, Schaid DJ, et al (1993) Phase III evaluation of four doses of megestrol acetate therapy for patients with cancer anorexia and/or cachexia. J Clin Oncol 11:762–767
Lubitz JD, Riley GF (1993) Trends in Medicare payments in the last year of life. N Engl J Med 328:1092–1096
McCullough LB (1992) A primer on bioethics. In: McCullough LB, Bauer J, Kindig D, Schenke R (eds) Review course for the ABMM examination. American College of Physician Executives, Boston, pp 1–20
McCusker J (1984) The terminal period of cancer: definition and descriptive epidemiology. J Chronic Dis 37:377–385
Micetich KC, Steinecker PH, Thomasma DC (1983) Are intravenous fluids morally required for a dying patient? Arch Intern Med 143:975–978
Miller RJ (1991) Predicting survival in the advanced cancer patient. Henry Ford Hosp Med J 39:81–83
Mor V (1987) The cost of hospice. In: Mor V (ed) Hospice care systems, structure, process costs, and outcomes. Springer, Berlin Heidelberg New York, pp 177–212
Mor V (1987) Quality of life outcomes. In: Mor V (ed) Hospice care systems, structure, process, costs, and outcomes. Springer, Berlin Heidelberg New York, pp 125–176
Mor V, Masterson-Allen S (1990) A comparison of hospice vs conventional care of the terminally ill cancer patient. Oncology 4:85–91
Mor V, Laliberte L, Morris JN, et al (1984) The Karnofsky Performance Status Scale, an examination of its reliability and validity in a research setting. Cancer 53:2002–2007
Mor V, Greer DS, Goldberg R (1988) The medical and social service interventions of hospice and nonhospice patients. In: Mor V, Greer D, Kastenbaum R (eds) The hospice experiment. Johns Hopkins, Baltimore, pp 88–108
Morris JN, Sherwood S, Wright SM, Gutkin CE (1988) The last weeks of life: does hospice care make a difference? In: Mor V, Greer D, Kastenbaum R (eds) The hospice experiment. Johns Hopkins, Baltimore, pp 109–132
Mullen JL (1981) Complications of total parenteral nutrition in the cancer patient. Cancer Treat Rep 65 [Suppl 5]:107–113
Needs and responses — the hospice approach (1983) In: Corr CA, Coor DM (eds) Hospice care, principles and practice. Springer, Berlin Heidelberg New York, pp 1–4
Nelson KA, Walsh TD (1993) Metoclopramide in anorexia caused by cancer-associated dyspepsia syndrome (CADS). J Palliat Care 9:14–18
Nelson KA, Walsh D, Sheehan FA (1994) The cancer anorexia-cachexia syndrome. J Clin Oncol 12:213–225
NHO Newsline (1993) 1992 stats show continued growth in programs and patients. NHO Newsline 3:1–2
Nixon DW (1986) The value of parenteral nutrition support. Chemotherapy and radiation treatment. Cancer 58:1902–1903
Oliver D (1993) Ethical issues in palliative care — an overview. Palliat Med 7 [Suppl 2]:15–20
Ovesen L, Allingstrup L, Hannibal J, et al (1993) Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. J Clin Oncol 11:2043–2049
Parkes CM (1972) Accuracy of predictions of survival in later stages of cancer. Br Med J II:29–31
Phillips PA, Rolls BJ, Ledingham JGG, et al (1984) Reduced thirst after water deprivation in healthy elderly men. N Engl J Med 311:753–759
Portenoy RK, Coyle N (1990) Controversies in the long-term management of analgesic therapy in patients with advanced cancer. J Pain Symptom Manage 5:307–319
Printz LA (1988) Is withholding hydration a valid comfort measure in the terminally ill? Geriatrics 43:85–88
Reuben DB, Mor V (1986) Dyspnea in terminally ill cancer patients. Chest 89:234–236
Reuben DB, Mor V, Hiris J (1988) Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med 148:1586–1591
Rhymes J (1990) Hospice care in America. JAMA 264:369–372
Rogers DF, Barnes PG (1989) Opioid inhibition of neurally mediated mucous secretion in human bronchi. Lancet I:930–931
Rosenthal MA, Gebski VJ, Kefford RF, et al (1993) Prediction of life-expectancy in hospice patients: identification of novel prognostic factors. Palliat Med 7:199–204
Rousseau PC (1991) How fluid deprivation affects the terminally ill. RN, January, pp 73–76
Santiago TV, Edelman NH (1985) Opioids and breathing. J Appl Physiol 59:1675–1685
Saunders CM (1983) The last stages of life. In: Corr CA, Coor DM (eds) Hospice care, principles and practice. Springer, Berlin Heidelberg New York, pp 5–11
Schonwetter RS, Teasdale TA, Storey P, Luchi RJ (1990) Estimation of survival time in terminal cancer patients: an impedance to hospice admissions? Hospice J 6:65–79
Scott AG (1994) Nasogastric feeding in the management of severe dysphagia in motor neurone disease. Palliat Med 8:45–49
Smith DH, Granbois JA (1982) The American way of hospice. Hastings Cent Rep 11:8–10
Souba WW, Copeland EM (1989) Hyperalimentation in cancer. CA Cancer J Clin 39:105–113
Stuart SP, Tiley EH, Boland JP (1993) Feeding gastrostomy: a critical review of its indications and mortality rate. South Med J 86:169–172
Tchekmedyian NS, Hickman M, Siau J, et al (1990) Treatment of cancer anorexia with megestrol acetate: impact on quality of life. Oncology 4:184–192
Von Roenn JH, Cleeland CS, Gonin R, et al (1993) Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology group. Ann Intern Med 119:121–126
Wallston KA, Burger C, Smith RA, Baugher RJ (1988) Comparing the quality of death for hospice and nonhospice cancer patients. Med Care 26:177–182
Woodcock AA, Gross ER, Gellert A, et al (1981) Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. N Engl J Med 305:1611–1616
Yates JW, Chalmer B, McKegney FP (1980) Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 45:2220–2224
Ziegler TR, Young LS, Benfell K, et al (1992) Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. Ann Intern Med 116:821–828
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kinzbrunner, B.M. Ethical dilemmas in hospice and palliative care. Support Care Cancer 3, 28–36 (1995). https://doi.org/10.1007/BF00343918
Issue Date:
DOI: https://doi.org/10.1007/BF00343918